Exagen, Inc. (XGN)
4.13
-0.28
(-6.35%)
USD |
NASDAQ |
Nov 13, 16:00
4.125
0.00 (0.00%)
After-Hours: 19:59
Exagen Enterprise Value : 105.65M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 105.65M |
| November 12, 2026 | 112.77M |
| November 11, 2026 | 128.66M |
| November 10, 2026 | 134.38M |
| November 09, 2026 | 181.15M |
| November 06, 2026 | 148.36M |
| November 05, 2026 | 193.86M |
| November 04, 2026 | 217.00M |
| November 03, 2026 | 212.67M |
| November 02, 2026 | 213.95M |
| October 30, 2026 | 219.03M |
| October 29, 2026 | 221.83M |
| October 28, 2026 | 214.20M |
| October 27, 2026 | 198.44M |
| October 26, 2026 | 190.56M |
| October 23, 2026 | 185.47M |
| October 22, 2026 | 190.81M |
| October 21, 2026 | 200.98M |
| October 20, 2026 | 189.03M |
| October 19, 2026 | 189.54M |
| October 16, 2026 | 196.91M |
| October 15, 2026 | 218.27M |
| October 14, 2026 | 214.71M |
| October 13, 2026 | 216.23M |
| October 12, 2026 | 210.39M |
| Date | Value |
|---|---|
| October 09, 2026 | 214.71M |
| October 08, 2026 | 208.35M |
| October 07, 2026 | 211.66M |
| October 06, 2026 | 208.86M |
| October 05, 2026 | 215.72M |
| October 02, 2026 | 208.35M |
| October 01, 2026 | 201.24M |
| September 30, 2026 | 207.34M |
| September 29, 2026 | 203.87M |
| September 28, 2026 | 208.23M |
| September 25, 2026 | 214.03M |
| September 24, 2026 | 214.52M |
| September 23, 2026 | 209.92M |
| September 22, 2026 | 214.52M |
| September 21, 2026 | 211.61M |
| September 18, 2026 | 206.53M |
| September 17, 2026 | 193.47M |
| September 16, 2026 | 191.29M |
| September 15, 2026 | 184.27M |
| September 14, 2026 | 180.89M |
| September 11, 2026 | 173.15M |
| September 10, 2026 | 171.69M |
| September 09, 2026 | 179.92M |
| September 08, 2026 | 179.68M |
| September 04, 2026 | 186.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 643.96M |
| BioRestorative Therapies, Inc. | -1.659M |
| CareDx, Inc. | 3.864B |
| Natera, Inc. | 45.20B |
| Sera Prognostics, Inc. | 39.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.336M |
| Revenue (Quarterly) | 18.42M |
| Total Expenses (Quarterly) | 24.75M |
| EPS Diluted (Quarterly) | -0.255 |
| Gross Profit Margin (Quarterly) | 58.84% |
| Profit Margin (Quarterly) | -34.40% |
| Earnings Yield | -18.20% |
| Normalized Earnings Yield | -18.16 |